Literature DB >> 23775968

New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation.

Saulius Girnius, David C Seldin, Maria Teresa Cibeira, Vaishali Sanchorawala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23775968     DOI： 10.1200/JCO.2013.48.7736

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

1.  Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting.

Authors:  Christopher P Venner; Julian D Gillmore; Sajitha Sachchithanantham; Shameem Mahmood; Thirusha Lane; Darren Foard; Murielle Roussel; Lisa Rannigan; Simon Dj Gibbs; Jennifer H Pinney; Carol J Whelan; Helen J Lachmann; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  Haematologica       Date:  2014-09-05       Impact factor: 9.941

2.  Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement.

Authors:  S Girnius; D C Seldin; H K Meier-Ewert; J M Sloan; K Quillen; F L Ruberg; J L Berk; G Doros; V Sanchorawala
Journal:  Bone Marrow Transplant       Date:  2013-12-09       Impact factor: 5.483

3.  A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis.

Authors:  Vaishali Sanchorawala; Giovanni Palladini; Vishal Kukreti; Jeffrey A Zonder; Adam D Cohen; David C Seldin; Angela Dispenzieri; Arnaud Jaccard; Stefan O Schönland; Deborah Berg; Huyuan Yang; Neeraj Gupta; Ai-Min Hui; Raymond L Comenzo; Giampaolo Merlini
Journal:  Blood       Date:  2017-05-26       Impact factor: 22.113

4.  Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis.

Authors:  Minjung Bak; Darae Kim; Jin-Oh Choi; Kihyun Kim; Seok Jin Kim; Eun-Seok Jeon
Journal:  Front Cardiovasc Med       Date:  2022-06-24

5.  New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation.

Authors:  Anita D'Souza; Jiaxing Huang; Parameswaran Hari
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-29       Impact factor: 5.742

Review 6.  Update on treatment of light chain amyloidosis.

Authors:  Shameem Mahmood; Giovanni Palladini; Vaishali Sanchorawala; Ashutosh Wechalekar
Journal:  Haematologica       Date:  2014-02       Impact factor: 9.941

7.  Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation.

Authors:  M Hasib Sidiqi; Mohammed A Aljama; Eli Muchtar; Francis K Buadi; Rahma Warsame; Martha Q Lacy; Angela Dispenzieri; David Dingli; Nelson Leung; Wilson I Gonsalves; Shaji K Kumar; Prashant Kapoor; Taxiarchis V Kourelis; William J Hogan; Morie A Gertz
Journal:  Blood Adv       Date:  2018-04-10

8.  [The consensus of the diagnosis and treatment of primary light chain amyloidosis in China (2016 version)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2016-09-14

9.  [Primary light chain amyloidosis onset with acquired FX deficiency: a case report and literature review].

Authors:  C Wei; J Feng; T N Zhu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-08-14

10.  Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis.

Authors:  Shayna Sarosiek; Luke Zheng; J Mark Sloan; Karen Quillen; Dina Brauneis; Vaishali Sanchorawala
Journal:  Blood Cancer J       Date:  2020-09-01       Impact factor: 11.037
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.